India’s AI pharmacy network market is attracting fresh investment as Bengaluru-based Plazza raises $15 million in Series A funding to expand its technology-enabled medicine delivery model. The round was co-led by Accel, Elevation Capital and Nexus Venture Partners, with existing investors All In Capital and Better Capital also participating. Plazza plans to use the capital to improve its AI-powered inventory technology, strengthen operations and expand its pharmacy footprint into new markets.
Founded in 2024 by former Zomato executive Aman Priyadarshi, Plazza combines neighborhood pharmacies, digital ordering and hyperlocal fulfillment to deliver medicines in approximately 15 to 30 minutes. The model aims to address a challenge that conventional pharmacies often face: keeping enough of the right medicines available for local prescription demand.
AI Pharmacy Network Raises $15 Million
Plazza’s latest financing represents a major step up from its previous funding. The startup raised about $1.4 million from All In Capital and Better Capital in 2025 before securing the new $15 million Series A.
The company also reported nearly 27-fold growth in gross merchandise value between June 2025 and March 2026, suggesting strong early demand for its rapid pharmacy delivery model.
The new capital will be directed toward three major priorities: technology, operational capabilities and network expansion. Plazza specifically intends to deepen its AI-driven inventory and assortment intelligence so individual pharmacies can carry medicines that are more closely aligned with local demand.
AI Pharmacy Network Uses Local Demand Data
Managing medicine inventory differs considerably from stocking conventional quick-commerce products.
Pharmacies must handle thousands of medicines across brands, dosages and formulations, while demand can vary depending on physicians, patient populations and prescribing patterns in each neighborhood.
Plazza says its AI-powered inventory planning system analyzes neighborhood-level prescribing patterns to determine what each store should stock. The objective is to improve prescription fulfillment while avoiding unnecessary inventory.
This approach makes inventory intelligence central to the company’s business model rather than using AI only for customer recommendations or marketing.
Rapid Medicine Delivery Drives Expansion
Plazza currently promises medicine delivery within approximately 15 to 30 minutes. Unlike models that fulfill prescriptions from large centralized warehouses located farther away, the startup uses technology-enabled neighborhood pharmacies positioned close to customers.
This hyperlocal structure is similar to quick commerce operationally, but pharmaceutical retail creates additional complexity because customers frequently require a specific combination of medicines rather than interchangeable products.
Fast delivery therefore has limited value if the requested prescription cannot be completely fulfilled.
AI Pharmacy Network Focuses on Availability
Plazza is attempting to solve speed and availability together.
According to founder Aman Priyadarshi, the company views its primary competition as India’s large offline pharmacy market rather than only established e-pharmacy businesses. Plazza argues that pharmaceutical retail requires deeper and more specialized inventory than conventional fast-commerce categories.
Moneycontrol reported that Plazza offers approximately 35,000 stock-keeping units and has grown from around 2,000 monthly orders in December to roughly 20,000 monthly orders, serving approximately 50,000 customers.
These figures indicate why sophisticated inventory planning could become increasingly important as order volume rises.
Pharmacy Network Prepares for Growth
At the time of its Series A announcement, Plazza operated two stores and was preparing to add eight more within one to two months. The startup was targeting around 20 Bengaluru locations by December 2026 before expanding more broadly.
Expanding a physical pharmacy network requires considerably more capital than operating only an online marketplace.
The company must manage retail facilities, medicine inventory, pharmacists, logistics, local demand forecasting and technology systems simultaneously.
The $15 million round gives Plazza additional resources to build that infrastructure while refining its technology.
AI Pharmacy Network Must Scale Reliably
Growth will test whether Plazza’s model can maintain prescription availability as it enters more neighborhoods and cities.
An inventory algorithm that performs effectively in one Bengaluru location may require different inputs in another area because prescribing patterns, patient demographics and physician networks can vary.
The company will therefore need to demonstrate that its AI systems can adapt to local markets without creating excessive stock or medicine shortages.
Medicine Delivery Requires Regulatory Compliance
Rapid pharmacy delivery also operates within a regulated healthcare environment.
India’s Central Drugs Standard Control Organization has established conditions governing doorstep medicine delivery by licensed retail pharmacies. Its rules require eligible retailers to maintain appropriate records and apply prescription requirements to regulated medicines. Certain controlled categories are excluded from doorstep delivery provisions.
Medicine transportation must also protect product integrity and patient confidentiality.
These requirements make pharmacy quick commerce different from delivering groceries or household products. Operational speed must remain compatible with prescription validation, safe handling, licensed dispensing and appropriate patient-data protection.
AI Pharmacy Network Targets Wider Healthcare Access
Plazza’s $15 million Series A demonstrates growing investor interest in applying quick-commerce infrastructure and artificial intelligence to pharmaceutical retail.
The opportunity is not simply to deliver medicines faster. The larger challenge is ensuring that the medicines patients need are actually available nearby when prescriptions are placed.
By combining neighborhood pharmacies with AI-driven assortment planning and hyperlocal delivery, Plazza is attempting to improve both availability and convenience.
Its next stage will test whether that model can expand beyond its early Bengaluru footprint while maintaining reliable fulfillment, regulatory compliance and operational efficiency.
If the company can successfully scale those capabilities, its AI pharmacy network could demonstrate how artificial intelligence and physical pharmacy infrastructure can work together to reshape medicine access in India’s rapidly evolving digital healthcare market.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
